ARTICLE | Clinical News
Second-generation multiple-epitope AIDS vaccine: To begin a Phase I study
April 18, 1994 7:00 AM UTC
Lederle Praxis (American Cyanamid) Product: Second-generation multiple-epitope AIDS vaccine Indication: Treat AIDS Status: National Institute of Allergy and Infectious Diseases will begin within 3-5 w...